Your browser doesn't support javascript.
loading
Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series.
Fricke, Jeremy; Wang, Joshua; Gallego, Natalie; Mambetsariev, Isa; Kim, Pauline; Babikian, Razmig; Chen, Bihong T; Afkhami, Michelle; Subbiah, Vivek; Salgia, Ravi.
Affiliation
  • Fricke J; Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, CA.
  • Wang J; Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, CA.
  • Gallego N; Columbia University, New York, NY.
  • Mambetsariev I; Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, CA.
  • Kim P; Department of Pharmacy, City of Hope National Medical Center, Duarte, CA.
  • Babikian R; Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, CA.
  • Chen BT; Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, CA.
  • Afkhami M; Department of Pathology, City of Hope, Duarte, CA.
  • Subbiah V; Department of Early-Phase Drug Development, Sarah Cannon Research Institute, Nashville, TN.
  • Salgia R; Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, CA. Electronic address: rsalgia@coh.org.
Clin Lung Cancer ; 24(7): 666-671, 2023 11.
Article in En | MEDLINE | ID: mdl-37580188

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chylous Ascites / Lung Neoplasms Limits: Humans Language: En Journal: Clin Lung Cancer Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chylous Ascites / Lung Neoplasms Limits: Humans Language: En Journal: Clin Lung Cancer Year: 2023 Document type: Article